Trial · NCT00278863
Adverse events26
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 26
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | S-1 for 2 Week on/1 Week Off | 37 | 42 | |
| other | Anemia | Blood and lymphatic system disorders | Capecitabine 2 Weeks on/1 Week Off | 39 | 44 | |
| other | Leukopenia | Blood and lymphatic system disorders | S-1 for 2 Week on/1 Week Off | 14 | 42 | |
| other | Leukopenia | Blood and lymphatic system disorders | Capecitabine 2 Weeks on/1 Week Off | 10 | 44 | |
| other | Neutropenia | Blood and lymphatic system disorders | S-1 for 2 Week on/1 Week Off | 10 | 42 | |
| other | Neutropenia | Blood and lymphatic system disorders | Capecitabine 2 Weeks on/1 Week Off | 13 | 44 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | S-1 for 2 Week on/1 Week Off | 12 | 42 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Capecitabine 2 Weeks on/1 Week Off | 12 | 44 | |
| other | Asthenia | General disorders | S-1 for 2 Week on/1 Week Off | 34 | 42 | |
| other | Asthenia | General disorders | Capecitabine 2 Weeks on/1 Week Off | 34 | 44 | |
| other | Anorexia | Gastrointestinal disorders | S-1 for 2 Week on/1 Week Off | 31 | 42 | |
| other | Anorexia | Gastrointestinal disorders | Capecitabine 2 Weeks on/1 Week Off | 38 | 44 | |
| other | Nausea | Gastrointestinal disorders | S-1 for 2 Week on/1 Week Off | 23 | 42 | |
| other | Nausea | Gastrointestinal disorders | Capecitabine 2 Weeks on/1 Week Off | 22 | 44 | |
| other | Vomiting | Gastrointestinal disorders | S-1 for 2 Week on/1 Week Off | 10 | 42 | |
| other | Vomiting | Gastrointestinal disorders | Capecitabine 2 Weeks on/1 Week Off | 10 | 44 | |
| other | Abdominal pain | Gastrointestinal disorders | S-1 for 2 Week on/1 Week Off | 20 | 42 | |
| other | Abdominal pain | Gastrointestinal disorders | Capecitabine 2 Weeks on/1 Week Off | 19 | 44 | |
| other | Stomatitis | Gastrointestinal disorders | S-1 for 2 Week on/1 Week Off | 9 | 42 | |
| other | Stomatitis | Gastrointestinal disorders | Capecitabine 2 Weeks on/1 Week Off | 24 | 44 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00278863/events